Masimo Corp

MASI

$93.70

-35.2% last 12 months

Ensemble Capital Holding value: $34.5 Million Ken Griffin Holding value: $24.1 Million Steven Cohen Holding value: $17.5 Million Baillie Gifford Holding value: $8.55 Million Mario Gabelli Holding value: $7.92 Million Ray Dalio Holding value: $4.98 Million Joel Greenblatt Holding value: $492 Thousand Jefferies Group Holding value: $204 Thousand Paul Tudor Jones II Holding value: $0 Chuck Royce Holding value: $0 Ron Baron Holding value: $0 Polen Capital Holding value: $0 Terry Smith Holding value: $0 Jeremy Grantham Holding value: $0 Jim Simons Holding value: $0 George Soros Holding value: $0

Market Cap

$4.9 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$75.22 - $198.00

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

55.31x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $4.9 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $5.71 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $0.00 (0.0%)
1 Year Return Profit or loss of share price change plus dividend yield. -35.2%
52-Week High Highest share price in the last 52 weeks. $198.00
52-Week Low Lowest share price in the last 52 weeks. $75.22
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.0
Outstanding Shares The number of shares the company has issued and are held by stockholders. 52.8 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 1.08 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 55.31
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. -76.79
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $1.63
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 2.34
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.9
Enterprise Value to Revenue Enterprise value divided by revenue 2.7
Enterprise Value to EBIT Enterprise Value divided by EBIT 33.03
Total Debt to Enterprise Value Total debt divided by enterprise value 0.16
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.74

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $2.12 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $1.05 Billion
EBIT Earnings before tax and interest payments. $173 Million
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. $88.5 Million
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 4.18%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -72.0%
Return on Equity Equity divided by market cap. 6.94%
Return on Assets Indicates a company's profitability in relation to its total assets. 2.95%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 7.15%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q1 2023 Q2 2023 Q3 2023 Q4 2023

About Masimo Corp

CEO: Joe Kiani

Industry: Electromedical and Electrotherapeutic Apparatus Manufacturing

Similar stocks

Resmed Inc.
Resmed Inc.
Koninklijke Philips N.V. - ADR
Koninklijke Philips N.V. - ADR
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
UFP Industries Inc
UFP Industries Inc
Cardinal Health, Inc.
Cardinal Health, Inc.
General Electric Co.
General Electric Co.
Owens & Minor, Inc.
Owens & Minor, Inc.
Conmed Corp.
Conmed Corp.

News

Column: How activist hedge fund Politan won $18 million in legal fees against Masimo

Column: How activist hedge fund Politan won $18 million in legal fees against Masimo

If you are going to deprecate the corporate benefit of intensely-fought litigation that cleared the way for shareholders to elect two independent board membe...

Reuters Reuters, 3 days ago
Zoom Video, Agilent And 3 Stocks To Watch Heading Into Monday

Zoom Video, Agilent And 3 Stocks To Watch Heading Into Monday

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Agile...

Benzinga Benzinga, 11 days ago
Masimo W1 watch gets FDA clearance for OTC, prescription use

Masimo W1 watch gets FDA clearance for OTC, prescription use

The FDA has cleared Masimo''s (MASI) W1 medical watch for prescription and over-the-counter use. Read more here.

Seeking Alpha Seeking Alpha, 13 days ago
Eminence Capital scoops up new stakes in Masimo, SentinelOne, exits New Relic

Eminence Capital scoops up new stakes in Masimo, SentinelOne, exits New Relic

Eminence Capital''s latest 13F filing reveals new positions in Masimo and SentinelOne while closing out positions in New Relic, Envista Holdings, and…

Seeking Alpha Seeking Alpha, 15 days ago
Never miss a trade
To improve your user experience we use cookies.